nach oben

Current Gastroenterology Reports

Erschienen in:

01.12.2021 | Pediatric Gastroenterology (S Orenstein and S Khan, Section Editors)

Newborn Screening for Biliary Atresia: a Review of Current Methods

verfasst von: Tebyan Rabbani, Stephen L. Guthery, Ryan Himes, Benjamin L. Shneider, Sanjiv Harpavat

Erschienen in: Current Gastroenterology Reports | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Biliary atresia is a serious neonatal liver disease due to obstructed bile ducts that has better outcomes when detected and treated in the first 30–45 days of life. This review examines different methods to screen newborns for biliary atresia as well as discusses observations from ongoing screening programs implemented in parts of the United States.

Recent Findings

Screening strategies for biliary atresia include detecting persistent jaundice, examining stool color, testing fractionated bilirubin levels, or measuring bile acid levels from dried blood spot cards. The stool color card program is the most widely used screening strategy worldwide. An alternative approach under investigation in the United States measures fractionated bilirubin levels, which are abnormal in newborns with biliary atresia. Fractionated bilirubin screening programs require laboratories to derive reference ranges, nurseries to implement universal testing, and healthcare systems to develop infrastructure that identifies and acts upon abnormal results.

Summary

Biliary atresia meets the disease-specific criteria for newborn screening. Current studies focus on developing a strategy which also meets all test-specific criteria. Such a strategy, if implemented uniformly, has the potential to accelerate treatment and reduce biliary atresia’s large liver transplant burden.

Nur mit Berechtigung zugänglich

Bezerra JA, Wells RG, Mack CL, et al. Biliary atresia: clinical and research challenges for the twenty-first century. Hepatology. 2018;68(3):1163–73. https://doi.org/10.1002/hep.29905.CrossRefPubMed

Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH. Screening and outcomes in biliary atresia: Summary of a national institutes of health workshop. In: Hepatology. Vol 46. Hepatology; 2007:566–581. doi:10.1002/hep.21790.

Hopkins PC, Yazigi N, Nylund CM. Incidence of biliary atresia and timing of Hepatoportoenterostomy in the United States. J Pediatr. 2017;187:253–7. https://doi.org/10.1016/j.jpeds.2017.05.006.CrossRefPubMed

Wilson JMG JG. Principles and Practice of Screening for Disease. WHO Public Paper 34.; 1968. Accessed June 23, 2021. https://apps.who.int/iris/bitstream/handle/10665/37650/WHO_PHP_34.pdf.

5.•

Mowat AP, Davidson LL, Dick MC. Earlier identification of biliary atresia and hepatobiliary disease: selective screening in the third week of life. Arch dis child. 1995;72(1):90-92. https://doi.org/10.1136/adc.72.1.90. Results from one of the earliest studies to screen infants that are jaundice with serum conjugated bilirubin measurements.

Hyperbilirubinemia S. On. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. https://doi.org/10.1542/peds.114.1.297.CrossRef

Bergman DA, Cooley JR, Coombs JB, et al. Practice parameter: Management of hyperbilirubinemia in the healthy term newborn. Pediatrics. 1994;94(4 I):558–565.

Thomas K. McInerny, Henry M. Adam, Deborah E. Campbell JMF and DMK. AAP Textbook of Pediatric Care, 2nd Ed. (Deepak M. TKAMHMCDEFJMK, ed.). American Academy of Pediatrics; 2016. https://ebooks.aappublications.org/content/9781610020473/9781610020473.

Kramer LI. Advancement of dermal Icterus in the jaundiced newborn. Am J Dis Child. 1969;118(3):454–8. https://doi.org/10.1001/archpedi.1969.02100040456007.CrossRefPubMed

10.

Madlon-Kay DJ. Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer. Pediatrics. 1997;100(3). doi:10.1542/peds.100.3.e3.

11.

Franciscovich A, Vaidya D, Doyle J, et al. Poop MD, a mobile health application, accurately identifies infant acholic stools. PLoS One. 2015;10(7):132270. https://doi.org/10.1371/journal.pone.0132270.CrossRef

12.•

Gu YH, Yokoyama K, Mizuta K, et al. Stool color card screening for early detection of biliary atresia and long-term native liver survival: a 19-year cohort study in Japan. J Pediatr. 2015;166(4):897-902.e1. Doi:https://doi.org/10.1016/j.jpeds.2014.12.063. Piviotal article discussing the results of the first stool color card program which was established in 1994 in Tochigi prefecture, Japan.

13.

Howard ER, MacLean G, Nio M, Donaldson N, Singer J, Ohi R. Survival patterns in biliary atresia and comparison of quality of life of long-term survivors in Japan and England. J Pediatr Surg. 2001;36(6):892–7. https://doi.org/10.1053/jpsu.2001.23965.CrossRefPubMed

14.•

Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics. 2006;117(4):1147-1154. https://doi.org/10.1542/peds.2005-1267. Taiwan implemented the first ever national biliary atresia screening program.

15.

Lee M, Chen SCC, Yang HY, Huang JH, Yeung CY, Lee HC. Infant stool color card screening helps reduce the hospitalization rate and mortality of biliary atresia a 14-year nationwide cohort study in Taiwan. Med (United States). 2016;95(12). https://doi.org/10.1097/MD.0000000000003166.

16.

Lien TH, Chang MH, Wu JF, et al. Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology. 2011;53(1):202–8. https://doi.org/10.1002/hep.24023.CrossRefPubMed

17.

Madadi-Sanjani O, Blaser J, Voigt G, Kuebler JF, Petersen C. Home-based color card screening for biliary atresia: the first steps for implementation of a nationwide newborn screening in Germany. Pediatr Surg Int. 2019;35(11):1217–22. https://doi.org/10.1007/s00383-019-04526-w.CrossRefPubMed

18.

Woolfson JP, Schreiber RA, Butler AE, et al. Province-wide biliary atresia home screening program in British Columbia: evaluation of first 2 years. J Pediatr Gastroenterol Nutr. 2018;66(6):845–9. https://doi.org/10.1097/MPG.0000000000001950.CrossRefPubMed

19.

Borgeat M, Korff S, Wildhaber BE. Newborn biliary atresia screening with the stool colour card: a questionnaire survey of parents. BMJ Paediatr Open. 2018;2(1):269. https://doi.org/10.1136/bmjpo-2018-000269.CrossRef

20.

Bezerra JA. Biliary atresia in Brazil: where we are and where we are going. J Pediatr. 2010;86(6):445–7. https://doi.org/10.2223/JPED.2057.CrossRef

21.

COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE BFPSW. 2021 recommendations for preventive pediatric health care. Pediatrics. 2021;147(3). doi:10.1542/PEDS.2020-049776.

22.

Harpavat S, Finegold MJ, Karpen SJ. Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatrics. 2011;128(6).https://doi.org/10.1542/peds.2011-1869.

23.•

Keffler S, Kelly DA, Powell JE, Green A. Population screening for neonatal liver disease: a feasibility study. J Pediatr Gastroenterol Nutr. 1998;27(3):306-311. https://doi.org/10.1097/00005176-199809000-00007. This was one of the earliest studies that screened all infants for liver disease with fractionated bilirubin.

24.

Powell JE, Keffler S, Kelly DA, Green A. Population screening for neonatal liver disease: potential for a community-based Programme. J Med Screen. 2003;10(3):112–6. https://doi.org/10.1177/096914130301000303.CrossRefPubMed

25.

Harpavat S, Garcia-Prats JA, Shneider BL. Newborn bilirubin screening for biliary atresia. N Engl J Med. 2016;375(6):605–6. https://doi.org/10.1056/nejmc1601230.CrossRefPubMed

26.•

Harpavat S, Garcia-Prats JA, Anaya C, et al. Diagnostic yield of newborn screening for biliary atresia using direct or conjugated bilirubin measurements. JAMA - J am med Assoc. 2020;323(12):1141-1150.https://doi.org/10.1001/jama.2020.0837. Results from this study showed that measuring fractionated bilirubin is a viable method to screen for biliary atresia in the newborn period.

27.•

Masucci L, Schreiber RA, Kaczorowski J, Collet JP, Bryan S. Universal screening of newborns for biliary atresia: cost-effectiveness of alternative strategies. J med screen. 2019;26(3). https://doi.org/10.1177/0969141319832039. Study showing that implementing the stool color card has acceptable cost-effectiveness.

28.

Mushtaq I, Logan S, Morris M, et al. Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. Br Med J. 1999;319(7208):471–7. https://doi.org/10.1136/bmj.319.7208.471.CrossRef

29.

Zhou K, Lin N, Xiao Y, et al. Elevated bile acids in newborns with biliary atresia (BA). PLoS One. 2012;7(11):49270. https://doi.org/10.1371/journal.pone.0049270.CrossRef

30.

Davis AR, Rosenthal P, Escobar GJ, Newman TB. Interpreting conjugated bilirubin levels in newborns. J Pediatr. 2011;158(4):562. https://doi.org/10.1016/j.jpeds.2010.09.061.CrossRefPubMed

31.

Lo SF, Doumas BT. The status of bilirubin measurements in U.S. laboratories: why is accuracy elusive? Semin Perinatol. 2011;35(3):141–7. https://doi.org/10.1053/j.semperi.2011.02.008.CrossRefPubMed

32.

Ozarda Y. Reference intervals: Current status, recent developments and future considerations. Biochem Medica. 2016;26(1):5–16. doi:10.11613/BM.2016.001.

33.

Ho CKM, Chen C, Setoh JWS, Yap WWT, Hawkins RCW. Optimization of hemolysis, icterus and lipemia interference thresholds for 35 clinical chemistry assays: interference of chemistry assays by hemolysis, icterus and lipemia. Pract Lab Med. 2021;25(February):e00232. https://doi.org/10.1016/j.plabm.2021.e00232.CrossRefPubMedPubMedCentral

34.

CLSI. NBS01-A6 DVD: Making a Difference by Newborn Screening.; 2014. Accessed July 6, 2021. https://clsi.org/standards/products/newborn-screening/companion/nbs01a6dvd/.

35.

Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the north American society for pediatric gastroenterology, hepatology, and nutrition and the European society for pediatric gastroenterology, hepatology, and nutriti. J Pediatr Gastroenterol Nutr. 2017;64(1):154–68. https://doi.org/10.1097/MPG.0000000000001334.CrossRefPubMed

36.

Jancelewicz T, Barmherzig R, Chung CTS, et al. A screening algorithm for the efficient exclusion of biliary atresia in infants with cholestatic jaundice. J Pediatr Surg. 2015;50(3):363–70. https://doi.org/10.1016/j.jpedsurg.2014.08.014.CrossRefPubMed

37.

McDiarmid SV, Anand R, Lindblad AS. Studies of pediatric liver transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant. 2004;8(3):284–94. https://doi.org/10.1111/j.1399-3046.2004.00153.x.CrossRefPubMed

38.

Wildhaber BE. Biliary atresia: 50 years after the first Kasai. ISRN Surg. 2012;2012:1–15. https://doi.org/10.5402/2012/132089.CrossRef

39.

Mysore KR, Shneider BL, Harpavat S. Biliary atresia as a disease starting in utero: implications for treatment, diagnosis, and pathogenesis. J Pediatr Gastroenterol Nutr. 2019;69(4):396–403. https://doi.org/10.1097/MPG.0000000000002450.CrossRefPubMedPubMedCentral

40.

Pinto RB, Schneider ACR, da Silveira TR. Cirrhosis in children and adolescents: an overview. World J Hepatol. 2015;7(3):392–405. https://doi.org/10.4254/wjh.v7.i3.392.CrossRefPubMedPubMedCentral

Titel: Newborn Screening for Biliary Atresia: a Review of Current Methods
verfasst von: Tebyan Rabbani
Stephen L. Guthery
Ryan Himes
Benjamin L. Shneider
Sanjiv Harpavat
Publikationsdatum: 01.12.2021
Verlag: Springer US
Erschienen in: Current Gastroenterology Reports / Ausgabe 12/2021
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI: https://doi.org/10.1007/s11894-021-00825-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2021

Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate)

Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician’s Guide

Foregut Dysmotility in the Lung Transplant Patient

Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders

Processed Foods – Getting Back to The Basics

How I Approach Laryngopharyngoesophageal Reflux (LPR)